Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has voluntarily disclosed the publication and website submission of its ‘Samsung Biologics ESG Report 2025’, detailing its economic, social, and environmental achievements for FY2024.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Sustainability Report and Related Matters (Voluntary Disclosure)
- Report Name: Samsung Biologics ESG Report 2025
- Submission Date: September 5, 2025
- Submission Destination: Samsung Biologics Official Website (https://samsungbiologics.com/kr/sustainability/esg-report)
- Assurance Agency: BSI Group Korea
- Reporting & Assurance Standards:
- Reporting Standards: Prepared in accordance with GRI Standards 2021 (Referenced ISO 26000, UN Global Compact, SASB, ESRS, ISSB, TCFD, TNFD, and CDP)
- Assurance Standard: Verified under AA1000AS v3 (Complies with AA1000AP 4 AccountAbility Principles)
- Reporting Scope: Economic, social, and environmental performance from January 1, 2024, to December 31, 2024 (Includes 3-year quantitative trend data from 2022 to 2024; select major milestones include updates up to the 2025 publication date)
- Main Report Structure:
- MANAGEMENT REPORT: Letter to Stakeholders, Company & Business Overview, Our Progress
- STRATEGIC REPORT: Vision 2030, ESG Governance & Strategy, Double Materiality Assessment
- ESG PERFORMANCE REPORT: Detailed Performance in Governance, Environmental, and Social domains
- ESG FACTBOOK: Financial/Non-financial Figures, Standard Indices (GRI, ESRS, ISSB, TCFD, etc.), Independent Assurance Statements
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Detailed ESG Performance via Published Report
This disclosure provides notice of the publication of the 2025 ESG Report, which outlines the company’s non-financial performance and ESG strategic roadmap.
Accessing the full report via the disclosed website link to review specific progress across environmental, social, and governance pillars, along with third-party assurance statements, is essential.
Relevant details can be verified directly on the ESG report section of Samsung Biologics’ official website.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
